AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21091414
Drug: Physiotherapy interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy interventions including daily supervised, progressive exercises until discharge and a postoperative exercise booklet on discharge
Trial: 10793604
Drug: Cold sensation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold sensation from ethyl chloride spray
Trial: 8619185
Drug: Dacron patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacron patch angioplasty
Trial: 8619185
Drug: Vein patch
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vein patch angioplasty
Trial: 2906174
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg once daily
Trial: 7818116
Drug: Intravenous oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous oxycodone
Trial: 31014267
Drug: Moderate to
RxNorm normalized name: GenTeal Moderate to Severe Ophthalmic Gel Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate to vigorous physical activity (MVPA) split (≥45 min average daily MVPA)
Trial: 27987595
Drug: Twice-daily thoracic
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily thoracic radiotherapy (TRT) (45 Gy/30 fractions)
Trial: 27987595
Drug: Once-daily thoracic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily thoracic radiotherapy (TRT) (42 Gy/15 fractions)
Trial: 27987595
Drug: First chemotherapy-course
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First chemotherapy-course
Trial: 20522615
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (LD) pantoprazole (0.3 mg/kg)
Trial: 20522615
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose (MD) pantoprazole (0.6 mg/kg)
Trial: 20522615
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD) pantoprazole (1.2 mg/kg)
Trial: 20522615
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose (MD) pantoprazole (0.6 mg/kg) for EE
Trial: 20522615
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD) pantoprazole (1.2 mg/kg) for EE
Trial: 18847151
Drug: Nebulized steroid
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized steroid fluticasone (Flixotide Nebules)
Trial: 18847151
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (nebulized fluticasone and intravenous methylprednisolone)
Trial: 18847151
Drug: Flixotide treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flixotide treatment arm
Trial: 2106256
Drug: [1-13C]acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [1-13C]acetate infusion
Trial: 2106256
Drug: [2-13C]acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [2-13C]acetate infusion
Trial: 2106256
Drug: [1-13C]acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [1-13C]acetate infusion during exogenous glucose infusion
Trial: 2106256
Drug: [2-13C]acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [2-13C]acetate infusion during exogenous glucose infusion
Trial: 2106256
Drug: [1-14C]acetate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [1-14C]acetate infusion
Trial: 7030373
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nifedipine and propranolol
Trial: 7030373
Drug: Propranolol (50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (50% dosage reduction)
Trial: 30789934
Drug: Motivational patient
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational patient education including motivational communication techniques and repeated training until correct administration.
Trial: 30789934
Drug: Standard feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard feedback on erroneous administration steps without further assessment or reinforced training.
Trial: 30193275
Drug: Immediate reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate reduction to 0.4 mg of nicotine per gram of tobacco cigarettes
Trial: 30193275
Drug: Gradual reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradual reduction from 15.5 mg to 0.4 mg of nicotine per gram of tobacco cigarettes
Trial: 30193275
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maintenance on 15.5 mg of nicotine per gram of tobacco cigarettes)
Trial: 26797774
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose betahistine (2 × 24 mg daily)
Trial: 26797774
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose betahistine (3 × 48 mg daily)
Trial: 16257815
Drug: Once-weekly alendronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly alendronate 70 mg oral solution
Trial: 10499773
Drug: TA 1200
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA 1200 (1200 mg of thioctic acid)
Trial: 10499773
Drug: TA 600
RxNorm normalized name: Xenleta 600mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA 600 (600 mg of thioctic acid)
Trial: 8688994
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (R)
Trial: 8688994
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (T)
Trial: 17621203
Drug: Active exercise
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active exercise and education using a cognitive behavioral therapy (CBT) approach, delivered in eight 2-hour group sessions over 6 weeks by physiotherapists.
Trial: 15848558
Drug: 0.75 g
RxNorm normalized name: Allantoin 0.75 g in 75 g TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 g MMF twice a day with SRL
Trial: 15848558
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g MMF twice a day with SRL
Trial: 15848558
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g MMF twice a day with SRL
Trial: 15848558
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g MMF twice a day with CsA
Trial: 12364424
Drug: RAI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAI plus lithium for 6 days starting on the day of RAI therapy (G2)
Trial: 11803607
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (LPD) with 0.6 g of protein and 35 kcal/kg/day, recombinant human erythropoietin (rHuEPO) at a dose of 40 U kg/week, and keto acids (KA) 100 mg/kg/day (Group I)
Trial: 9667297
Drug: 0.0625% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0625% bupivacaine with 2.5 microg/ml fentanyl
Trial: 517720
Drug: Ethamsylate 1000
RxNorm normalized name: ethamsylate
DrugBank: Etamsylate (DB13483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethamsylate 1000 mg intravenously before induction of anaesthesia
Trial: 30620642
Drug: Standard exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard exercise guidelines (0.5 g CHO/kg/h when glucose <8 mmol/L)
Trial: 29540273
Drug: Usual diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual diet and placebo pills (n = 29)
Trial: 29540273
Drug: Usual diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual diet and antioxidant supplements (n = 29)
Trial: 29540273
Drug: Antioxidant-rich foods
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant-rich foods closely matched to antioxidant content of supplements and placebo (n = 30)
Trial: 11911557
Drug: 5-day gatifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day gatifloxacin 400 mg once daily
Trial: 11911557
Drug: 10-day gatifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day gatifloxacin 400 mg once daily
Trial: 11911557
Drug: 10-day amoxicillin/clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day amoxicillin/clavulanate 875 mg twice daily
Trial: 10419989
Drug: Dark green,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark green, leafy vegetables with fat (10 g/100 g)
Trial: 7869865
Drug: Conservative management;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative management; details on dosage and duration not specified.
Trial: 7869865
Drug: Surgery; details
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery; details on dosage and duration not specified.
Trial: 2073672
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg q.p.m. (doubled if LDL > 140 mg/dl after 6 weeks)
Trial: 6459256
Drug: Tizanidine (5-Chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine (5-Chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole), administered t.i.d. for 7 days
Trial: 6459256
Drug: Diazepam, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam, administered t.i.d. for 7 days
Trial: 29067761
Drug: Therapies that
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapies that improve outcomes in heart failure with reduced ejection fraction (HFrEF)
Trial: 25733635
Drug: High-flavanone (305
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flavanone (305 mg) 100% orange juice
Trial: 25733635
Drug: Low-flavanone (37
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flavanone (37 mg) orange-flavored cordial (500 mL)
Trial: 23032168
Drug: Meningococcal ACWY-tetanus
RxNorm normalized name: meningococcal ACWY, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal ACWY-tetanus toxoid conjugate vaccine (ACWY-TT group; n = 231)
Trial: 23032168
Drug: Licensed meningococcal
RxNorm normalized name: MENINGOCOCCAL B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Licensed meningococcal ACWY polysaccharide vaccine (Men-PS group; n = 78)
Trial: 18435692
Drug: Psychological characteristics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological characteristics assessed by a self-administered questionnaire
Trial: 12381039
Drug: Virtual-reality (VR)
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Virtual-reality (VR) treatment
Trial: 14565594
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg/day) plus calcium (1000 mg/day)
Trial: 7762531
Drug: Arabica coffee
RxNorm normalized name: arabica coffee oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arabica coffee oil (2 g daily)
Trial: 7762531
Drug: Robusta coffee
RxNorm normalized name: Robusta Coffee Bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robusta coffee oil (2 g daily)
Trial: 25421252
Drug: Capecitabine alone
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine alone (500-825 mg/m2/bid, days 1-21)
Trial: 25421252
Drug: Capecitabine plus
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine plus Valproic acid (oral daily, day -14 to 21, target serum level 50-100 microg/ml)
Trial: 7598669
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) - 10-session treatment package including progressive relaxation, rational thinking, and pain coping strategies.
Trial: 2358617
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Zn daily for 12 months
Trial: 2358617
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Zn daily for 12 months
Trial: 475632
Drug: One-half isotonic
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-half isotonic saline solution
Trial: 28616923
Drug: Tramadol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 0.5 mg/kg (TRM1)
Trial: 28616923
Drug: Tramadol 1
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1 mg/kg (TRM2)
Trial: 28616923
Drug: Tramadol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1.5 mg/kg (TRM3)
Trial: 25825006
Drug: Web-based monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based monthly monitoring with the Childhood Asthma Control Test (ACT)
Trial: 25825006
Drug: 4-monthly monitoring
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 4-monthly monitoring of FENO
Trial: 24068825
Drug: Quetiapine 150
RxNorm normalized name: quetiapine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 150 mg XL for 7 days
Trial: 12699266
Drug: Pretreatment with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pretreatment with GnRH agonists before IVF cycle initiation
Trial: 11092289
Drug: Nateglinide 120
RxNorm normalized name: nateglinide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide 120 mg before meals
Trial: 16827766
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg three times a day
Trial: 11092289
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (nateglinide + metformin)
Trial: 9170525
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus injection of 5 mg azasetron before and 8 hours after chemotherapy
Trial: 9170525
Drug: Standard group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard group receiving intravenous bolus injection of 10 mg azasetron once a day
Trial: 2971310
Drug: Celiprolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (400 mg once a day)
Trial: 30313092
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia (TIVA) (propofol and remifentanil)
Trial: 25913923
Drug: IR/ER HB/APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR/ER HB/APAP (7.5/325 mg) fixed-dose combination analgesic agent, initial dose of 22.5/975 mg on day 1, followed by 15/650 mg every 12 hours for up to 35 days.
Trial: 25913923
Drug: IR/ER HB/APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR/ER HB/APAP (7.5/325 mg) fixed-dose combination analgesic agent.
Trial: 24469870
Drug: N-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-3 polyunsaturated fatty acids (Omacor) 1 g daily
Trial: 24469870
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard therapy + 75 mg acetylsalicylic acid + 75 mg clopidogrel)
Trial: 19048591
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors alone or associated with corticosteroids
Trial: 1959498
Drug: Tetrabamate (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrabamate (900 mg/day)
Trial: 1959498
Drug: Lorazepam (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (4.5 mg/day)
Trial: 6753116
Drug: Pirenzepine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (100 mg/daily)
Trial: 25855267
Drug: Extended-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release carbidopa-levodopa (ER CD-LD) 97.5 mg-390 mg
Trial: 25855267
Drug: Immediate-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release carbidopa-levodopa (IR CD-LD) 25 mg-100 mg
Trial: 25855267
Drug: Sustained-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release carbidopa-levodopa (CR CD-LD) 25 mg-100 mg
Trial: 25855267
Drug: Carbidopa-levodopa-entacapone (Stalevo)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbidopa-levodopa-entacapone (Stalevo) 25 mg-100 mg-200 mg
Trial: 23942038
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose of levocetirizine
Trial: 23942038
Drug: Conventional dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose of levocetirizine
Trial: 19675538
Drug: Catecholamine depletion
RxNorm normalized name: Allogeneic thymocyte-depleted thymus tissue-agdc
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catecholamine depletion (CD) achieved by oral administration of alpha‐methyl‐paratyrosine (AMPT)
Trial: 17877165
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A + C meningococcal polysaccharide vaccine (100 microg)
Trial: 17877165
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A meningococcal polysaccharide vaccine (50 microg)
Trial: 17877165
Drug: Typhoid Vi
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid Vi polysaccharide vaccine (30 microg)
Trial: 2902263
Drug: Edmonston-Zagreb (EZ)
RxNorm normalized name: measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection [ProQuad]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb (EZ) measles vaccine, 40,000 plaque forming units
Trial: 2902263
Drug: Schwarz measles
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schwarz measles vaccine, 6000 tissue culture infectious units
Trial: 2902263
Drug: Edmonston-Zagreb (EZ)
RxNorm normalized name: measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection [ProQuad]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb (EZ) measles vaccine
Trial: 31204129
Drug: Single-dose Custodiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose Custodiol histidine‐tryptophan‐ketoglutarate
Trial: 16446183
Drug: Fondaparinux administered
RxNorm normalized name: Fondaparinux
DrugBank: Fondaparinux (DB00569)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fondaparinux administered 8 +/- 2 hours after surgery
Trial: 16446183
Drug: Fondaparinux administered
RxNorm normalized name: Fondaparinux
DrugBank: Fondaparinux (DB00569)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fondaparinux administered the morning after surgery
Trial: 12946548
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 microg BID via single-dose dry powder inhaler plus on‐demand salbutamol
Trial: 11194599
Drug: 5 mmol
RxNorm normalized name: dibasic potassium phosphate 15 MMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mmol intravenous magnesium
Trial: 11194599
Drug: 10 mmol
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mmol intravenous magnesium
Trial: 11194599
Drug: 20 mmol
RxNorm normalized name: dibasic potassium phosphate 120 MMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mmol intravenous magnesium
Trial: 11194599
Drug: 0 mmol
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mmol intravenous magnesium (placebo)
Trial: 2999455
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral acyclovir
Trial: 29658344
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCP)
Trial: 29658344
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M) + Oral contraceptives (OCP)
Trial: 27982406
Drug: Phytotherapy (Gan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytotherapy (Gan Mai Da Zao formula, 50 ml)